COVID-19

Covid-19 open window

Distance, Dose, Dispersion: An experts’ guide on Covid-19 risks in South Africa and how to manage them.

Daily Maveric By: Covid-19 academics and medical professionals, 26 June 2020 Understand the three things that can make the most difference to easing the Covid-19 lockdown and reopening South Africa with the least risk, whether you are using a taxi, socialising, working, working out, or running a shop. Understand that we may be in for …

Distance, Dose, Dispersion: An experts’ guide on Covid-19 risks in South Africa and how to manage them. Read More »

Business for SA – uFiling Webinar

UIF WEBCAST: RESPONSES TO WRITTEN QUERIES AT 17 June 2020 Business for South Africa (B4SA) conducted a webcast on 17 June 2020 to assist employers struggling with their UIF Temporary Employer/Employee Relief Scheme (TERS) benefit applications. There wasn’t time to answer all questions and individuals who posed questions in writing have received replies from our …

Business for SA – uFiling Webinar Read More »

COVID-19 VACCINE TRIAL – WITS UNIVERSITY BEGINS SA’S FIRST

COVID-19 vaccine trials to start in S. Africa Wits University on Tuesday said that it was beginning clinical trials for the first African COVID-19 vaccine on Wednesday. The announcement was made during a virtual press conference hosted by the university. The institution said that 2,000 people between the ages of 18 and 65 would be …

COVID-19 VACCINE TRIAL – WITS UNIVERSITY BEGINS SA’S FIRST Read More »

Dexamethasone

WHO moves to update COVID-19 guidance after ‘great news’ in Dexamethasone study

Dexamethasone is a low-cost drug which already exists and is in good supply. Dexamethasone was first made in 1957 and became available for use in the early 1960s. Because it’s been around for such a long time, the drug is out of patent, which means lots of different companies can make it and it is widely …

WHO moves to update COVID-19 guidance after ‘great news’ in Dexamethasone study Read More »

Scroll to Top